Mohammad Mahfuzul Haque
Overview
Explore the profile of Mohammad Mahfuzul Haque including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehandi R, Twala C, Ahmedi S, Fatima A, Islam K, Rana M, et al.
J Biomol Struct Dyn
. 2025 Jan;
43(4):1723-1755.
PMID: 39886763
1,3,4-Oxadiazole-based heterocyclic analogs (3a-3m) were synthesized cyclization of Schiff bases with substituted aldehydes in the presence of bromine and acetic acid. The structural clarification of synthesized molecules was carried out...
2.
Rathi A, Noor S, Sulaimani M, Ahmed S, Taiyab A, Alajmi M, et al.
Int J Biol Macromol
. 2024 Dec;
292:139107.
PMID: 39722389
PIM-1 kinase, a member of the Serine/Threonine kinase family, has emerged as a promising therapeutic target in various cancers due to its role in promoting tumor growth and resistance to...
3.
Singh P, Tabassum G, Masood M, Anwar S, Syed M, Dev K, et al.
3 Biotech
. 2024 Nov;
14(12):306.
PMID: 39583208
[This corrects the article DOI: 10.1007/s13205-024-04127-y.].
4.
Rathi A, Noor S, Khan S, Khan F, Anjum F, Ashraf A, et al.
Comput Biol Chem
. 2024 Nov;
113:108265.
PMID: 39488934
PIM-1 is a Ser/Thr kinase, which has been extensively studied as a potential target for cancer therapy due to its significant roles in various cancers, including prostate and breast cancers....
5.
Singh P, Tabassum G, Masood M, Anwar S, Syed M, Dev K, et al.
3 Biotech
. 2024 Oct;
14(11):273.
PMID: 39444988
Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-04127-y.
6.
Rathi A, Chaudhury A, Anjum F, Ahmad S, Haider S, Khan Z, et al.
Int J Biol Macromol
. 2024 Jul;
276(Pt 2):133882.
PMID: 39019373
PIM-1 kinase belongs to the Ser/Thr kinases family, an attractive therapeutic target for prostate cancer. Here, we screened about 100 natural substances to find potential PIM-1 inhibitors. Two natural compounds,...
7.
Haque M, Ghobakhlou A, Narayanan A
Sensors (Basel)
. 2024 Jul;
24(13).
PMID: 39000972
With the continuous development of new sensor features and tracking algorithms for object tracking, researchers have opportunities to experiment using different combinations. However, there is no standard or agreed method...
8.
Shiffa M, Kazmi M, Ali S, Anwar A, Yasir M, Fahamiya N, et al.
Altern Ther Health Med
. 2024 Apr;
30(5):6-13.
PMID: 38581340
Objectives: Continuous and excessive secretion of pro-inflammatory and anti-inflammatory chemicals and cytokines may further deteriorate inflammation. Anti-inflammatory drugs play an imperative role in inhibiting the evolution of inflammatory diseases. As...
9.
Gurung R, Masood M, Singh P, Jha P, Sinha A, Ajmeriya S, et al.
J Appl Genet
. 2024 Feb;
65(4):839-851.
PMID: 38358594
Head and neck squamous cell carcinoma (HNSC) is a diverse group of tumors arising from oral cavity, oropharynx, larynx, and hypopharynx squamous epithelium, posing significant morbidity. Aquaporins (AQPs) are membrane...
10.
Masood M, Singh P, Hariss D, Khan F, Yameen D, Siraj S, et al.
Gene
. 2024 Jan;
899:148148.
PMID: 38191100
In the face of the global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), researchers are tirelessly exploring novel therapeutic approaches to combat coronavirus disease 2019 (COVID-19) and its...